Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells-0

Abstract

<p><b>Copyright information:</b></p><p>Taken from "Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells"</p><p>BMC Cancer 2006;6():60-60.</p><p>Published online 15 Mar 2006</p><p>PMCID:PMC1434759.</p><p>Copyright © 2006 Goffinet et al; licensee BioMed Central Ltd.</p>nd D3, cells were treated by vehicle or increasing doses of zoledronate (ZOL: 5, 10, 15, 20 μM). At D5, the cells were fixed with TCA and stained with 0.4% sulforhodamine. Staining intensity was quantified at 540 nm. Results are expressed as the ratio OD/ODof three independent assays each performed six times. Error bars indicate inter-assay mean ± 1 SD. * indicates a significant difference versus non-treated cells (p < 0.01). PC3 PNT1A LNCa